ARCHIVES

Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 28 | July 11, 2003

Download PDF Visit The Full Archive

Related Articles

Drug Development Gets Extra $500,000

November 18, 1977

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

DCPC Board Commits More Than $100 Million To 15-Year Trial Of Low Fat Diet In Women

October 26, 1990

In Brief: Senate Bill Would Give NCI $1.034 Billion In 1982, $45 Million (3.5 Percent) More Than FY 1981 Budget

September 25, 1981

In Brief: Mary-Claire King Named Disney Professor By Cancer Society; Date Corrected In Article

July 1, 1994

Rauscher Says He May Leave, But Will Stay Through June

February 6, 1976